Inventor · disambiguated record
John I. Trujillo
Also filed as: TRUJILLO JOHN · TRUJILLO JOHN I · TRUJILLO JOHN ISIDRO
23 granted patents·15 pending applications·126 citations·filing 2000–2025
94Inventor score
Top patents by PatentIndex Score
38 records- 0195US9663526B2Aminopyrimidinyl compoundsPFIZER·Filed 2015·Granted May 30, 2017·22 cites·26 claims
- 0292US11197867B2Aminopyrimidinyl compoundsPFIZER·Filed 2020·Granted Dec 14, 2021·2 cites·9 claims
- 0392US7902373B2Nicotinamide derivativesPFIZER·Filed 2007·Granted Mar 8, 2011·35 cites·6 claims
- 0490US11708360B2N-substituted-dioxocyclobutenylamino-3-hydroxy-picolinamides useful as CCR6 inhibitorsPFIZER·Filed 2021·Granted Jul 25, 2023·2 cites·16 claims
- 0590US9617258B2Pyrrolo[2,3-d]pyrimidinyl, pyrrolo[2,3-b]pyrazinyl and pyrrolo[2,3-d]pyridinyl acrylamidesPFIZER·Filed 2014·Granted Apr 11, 2017·13 cites·6 claims
- 0688US10975065B2N-substituted-dioxocyclobutenylamino-3-hydroxy-picolinamides useful as CCR6 inhibitorsPFIZER·Filed 2019·Granted Apr 13, 2021·3 cites·14 claims
- 0788US7582643B2Heterocyclic compounds useful in treating diseases and conditionsPFIZER·Filed 2008·Granted Sep 1, 2009·14 cites·5 claims
- 0886US10463675B2Aminopyrimidinyl compoundsPFIZER·Filed 2017·Granted Nov 5, 2019·4 cites·2 claims
- 0985US10980815B2Aminopyrimidinyl compoundsPFIZER·Filed 2019·Granted Apr 20, 2021·2 cites·8 claims
- 1084US2025134869A1Pyrrolo[2,3-d]pyrimidinyl, Pyrrolo[2,3-b]pyrazinyl and Pyrrolo[2,3-d]pyridinyl Acryla-midesPFIZER·Filed 2024·Application pending·0 cites
- 1183US11661419B2Benzimidazole derivative compounds and uses thereofPFIZER·Filed 2020·Granted May 30, 2023·1 cites·23 claims
- 1281US8067589B2Heterocyclic compounds useful in treating diseases and conditionsBLAKE TANISHA D·Filed 2009·Granted Nov 29, 2011·10 cites·5 claims
- 1380US12312344B2N-substituted-dioxocyclobutenylamino-3-hydroxy-picolinamides useful as CCR6 inhibitorsPFIZER·Filed 2023·Granted May 27, 2025·0 cites·20 claims
- 1479US6664255B1Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascadePHARMACIA CORP·Filed 2000·Granted Dec 16, 2003·7 cites·27 claims
- 1574US2021377495A1Aminopyrimidinyl compoundsPFIZER·Filed 2021·Application pending·0 cites
- 1673US12077533B2Pyrrolo[2,3-d]pyrimidinyl, pyrrolo[2,3-b]pyrazinyl and pyrrolo[2,3-d]pyridinyl acrylamidesPFIZER·Filed 2021·Granted Sep 3, 2024·0 cites·2 claims
- 1771US7105559B2Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascadePHARMACIA CORP·Filed 2002·Granted Sep 12, 2006·5 cites·12 claims
- 1870US8293903B23-aminocyclopentanecarboxamides as chemokine receptor agonistsHUGHES ROBERT O·Filed 2010·Granted Oct 23, 2012·2 cites·4 claims
- 1967US12281122B1PI3K inhibitorsCOGENT BIOSCIENCES INC·Filed 2024·Granted Apr 22, 2025·0 cites·30 claims
- 2065US11111242B2Pyrrolo[2,3-d]pyrimidinyl, pyrrolo[2,3-b]pyrazinyl and pyrrolo[2,3-d]pyridinyl acrylamidesPFIZER·Filed 2017·Granted Sep 7, 2021·0 cites·12 claims
- 2165US8946413B23-aminocyclopentanecarboxamides as chemokine receptor agonistsHUGHES ROBERT O·Filed 2012·Granted Feb 3, 2015·1 cites·13 claims
- 2265US6908919B2Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascadePHARMACIA CORP·Filed 2002·Granted Jun 21, 2005·3 cites·27 claims
- 2363US2005137220A1Beta-carboline compounds and analogues thereof as mitogen-activated protein kinase-activated protein kinase-2 inhibitorsPHARMACIA CORP·Filed 2004·Application pending·0 cites
- 2462US2023280220A1Benzimidazole Derivative Compounds and Uses ThereofPFIZER·Filed 2023·Application pending·0 cites
- 2557US2024124439A1Pyrido[2,3-D]Imidazole Derivatives and Their Use As Inhibitors of ITK for the Treatment of Skin DiseasePFIZER·Filed 2021·Application pending·0 cites
- 2657US2024132477A1Benzimidazole Derivatives and Their Use As Inhibitors of ITK For The Treatment of Skin DiseasePFIZER·Filed 2021·Application pending·0 cites
- 2754US2005267123A16-Membered heterocyclic compounds useful for selective inhibition of the coagulation cascadePHARMACIA CORP·Filed 2005·Application pending·0 cites
- 2852US2005101623A1Beta-carboline compounds and analogues thereof as mitogen-activated protein kinase-activated protein kinase-2 inhibitorsPHARMACIA CORP·Filed 2004·Application pending·0 cites
- 2949US2010173888A1Nicotinamide DerivativesPFIZER·Filed 2009·Application pending·0 cites
- 3049US2005239860A1Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascadePHARMACIA CORP·Filed 2005·Application pending·0 cites
- 3148US10703756B2Pyrrolo[2,3-D]pyrimidinyl, pyrrolo[2,3-B]pyrazinyl, pyrrolo[2,3-B]pyridinyl acrylamides and epoxides thereofPFIZER·Filed 2016·Granted Jul 7, 2020·0 cites·5 claims
- 3248US2025206752A1Pi3k inhibitorsCOGENT BIOSCIENCES INC·Filed 2025·Application pending·0 cites
- 3348US2005043313A1Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascadePHARMACIA CORP·Filed 2004·Application pending·0 cites
- 3448US2004102448A1Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascadePHARMACIA CORP·Filed 2003·Application pending·0 cites
- 3546US6969715B26-membered heterocyclic compounds useful for selective inhibition of the coagulation cascadePHARMACIA CORP·Filed 2002·Granted Nov 29, 2005·0 cites·14 claims
- 3640US2004082585A1Prodrugs of substituted polycyclic compounds useful for selective inhibition of the coagulation cascadePHARMACIA CORP·Filed 2002·Application pending·0 cites
- 3737US2004106626A16-Membered unsaturated heterocyclic compounds useful for selective inhibition of the coagulation cascadePHARMACIA CORP·Filed 2002·Application pending·0 cites
- 3836US7119094B1Substituted polycyclic aryl and heteroarpyl pyrazinones useful for selective inhibition of the coagulation cascadeWARNER LAMBERT CO·Filed 2000·Granted Oct 10, 2006·0 cites·46 claims
Join the waitlist — get patent alerts
Get an alert when John I. Trujillo files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →